At week @ , infliximab-treated patients had greater mean reductions in erythrocyte sedimentation rate ( p = @ ) and a two-fold greater decrease in Z score of the left anterior descending artery ( p = @ ) than did those in the placebo group , but this difference was not significant at week @ .